Thomas Malley

Insider Reports History

Location
Hamilton, Bermuda
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Malley:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BeiGene, Ltd. Director Ordinary Shares 46.7K $9.7M $207.72 15 Jun 2023 Direct
BeiGene, Ltd. Director American Depositary Shares 30K $5.42M $180.50 15 Jun 2023 Direct
Kiniksa Pharmaceuticals International, plc Director Class A Ordinary Shares 72K $1.97M $27.44 12 Aug 2025 Indirect
Kiniksa Pharmaceuticals International, plc Director Class A Ordinary Shares 12.5K $415K $33.09 14 Aug 2025 Direct
Kura Oncology, Inc. Director Option to purchase common stock 28.5K 05 Jun 2025 Direct
BeiGene, Ltd. Director Share Option (Right to Buy) 27K 15 Jun 2023 Direct
Kura Oncology, Inc. Director Option to purchase common stock 26K 05 Jun 2024 Direct
Kiniksa Pharmaceuticals International, plc Director Restricted Share Units 0 05 Jun 2025 Direct
Kiniksa Pharmaceuticals International, plc Director Share Option 0 14 Aug 2025 Direct

Insider Reports Filed by Thomas Malley

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KNSA Kiniksa Pharmaceuticals International, plc 12 Aug 2025 17 -$4.04M 4 Director 14 Aug 2025, 16:59
KURA Kura Oncology, Inc. 05 Jun 2025 1 $0 4 Director 06 Jun 2025, 16:05
KNSA Kiniksa Pharmaceuticals International, plc 03 Jun 2025 4 $0 4 Director 05 Jun 2025, 17:02
KNSA Kiniksa Pharmaceuticals, Ltd. 05 Jun 2024 4 $0 4 Director 07 Jun 2024, 16:39
KURA Kura Oncology, Inc. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 16:30
KNSA Kiniksa Pharmaceuticals, Ltd. 29 Jun 2023 2 $0 4 Director 03 Jul 2023, 16:15
KURA Kura Oncology, Inc. 16 Jun 2023 1 $575K 4 Director 21 Jun 2023, 16:29
BGNE BeiGene, Ltd. 15 Jun 2023 2 $0 4 Director 20 Jun 2023, 19:00
KNSA Kiniksa Pharmaceuticals, Ltd. 06 Jun 2023 2 $0 4 Director 08 Jun 2023, 16:23
KURA Kura Oncology, Inc. 31 May 2023 1 $0 4 Director 02 Jun 2023, 16:53
KNSA Kiniksa Pharmaceuticals, Ltd. 29 Jun 2022 2 $0 4 Director 30 Jun 2022, 16:20
BGNE BeiGene, Ltd. 22 Jun 2022 2 $0 4 Director 24 Jun 2022, 17:37
KURA Kura Oncology, Inc. 21 Jun 2022 1 $0 4 Director 23 Jun 2022, 16:46
KNSA Kiniksa Pharmaceuticals, Ltd. 29 Jun 2021 1 $0 4 Director 30 Jun 2021, 16:21
KURA Kura Oncology, Inc. 22 Jun 2021 1 $0 4 Director 23 Jun 2021, 17:16
BGNE BeiGene, Ltd. 16 Jun 2021 2 $0 4 Director 21 Jun 2021, 16:37